SHOO

Current Thesis

The "worst-of-tariffs-is-behind-us" recovery in SHOO is largely PLAYED OUT, not accelerating. The stock has round-tripped from its ~$22 April-2025 tariff-crash low back to ~$43.80 (June 4 2026) — within 7% of the 52-wk high of $46.88 — and now sits essentially ON the $43.88 consensus PT. Q1 (reported 2026-05-06) printed +18.0% revenue YoY, but that is almost entirely the $360M Kurt Geiger acquisition (DTC +83.8% to $206.0M); organic DTC was only +8.0%, and adjusted diluted EPS FELL to $0.45 from [entry redacted] a year ago. The headline $1.00 GAAP EPS was flattered by a one-time $55.1M pre-tax tariff-recovery benefit. This is a maturing, sell-side-consensus turnaround — a Legacy Pivot, not the fresh accelerating leg this book exists to catch. The narrative the bulls own (China sourcing cut from 71% of US imports in 2024 to <10% by spring 2026; CEO Rosenfeld's "worst is behind us") is now widely understood and priced.

Bull Case

• Supply-chain de-risking executed, not promised. China fell from 71% of US imports (2024) to an expected <10% by spring 2026 (ex-Kurt Geiger), via CAFTA nearshoring + Vietnam/Cambodia/Brazil. This is structural tariff-insulation the market feared SHOO couldn't pull off.
• Guidance RAISED on Q1 call (2026-05-06): FY2026 revenue to +10–12% (from +9–11%), GAAP EPS $2.55–$2.65, adjusted EPS $2.00–$2.10. A raise into a tariff backdrop is a credibility signal.
• Kurt Geiger accretion building. $360M deal (closed May 2025) drove DTC +83.8% to $206.0M in Q1; management guides Kurt Geiger China sourcing down sharply for Spring 2026, reducing its tariff drag.
• Sell-side leaning positive at the margin: BTIG reiterated Buy / $50 PT (2026-06-04); management ran institutional meetings (Piper, Telsey, BTIG, Needham) early June 2026 — a soft positioning tailwind.
• Price action: ~10% price increases pushed through to partially offset FOB costs that run 10–15% above old China pricing.

Bear Case

• Adjusted EPS is DECLINING: $0.45 in Q1 vs $0.60 a year ago; FY2026 adjusted guide $2.00–$2.10 is below 2025. The "growth" is inorganic (Kurt Geiger); core organic DTC only +8.0%. You are buying decelerating real earnings dressed up by M&A and a one-off tariff credit.
• Already at consensus PT. Average analyst PT $43.88 vs ~$43.80 spot — zero margin of safety. UBS sits at $40 (below market). BTIG's $50 is the outlier, not the base case. Consensus rating: Hold.
• Tariff relief is now consensus, not edge. "Worst is behind us" was the April-2025 trade at $22; at $44 it's priced. FOB costs +10–15% are a permanent margin headwind, not a one-quarter event.
• Discretionary footwear is cyclically exposed — a consumer-spending wobble hits a name already at the top of its range with no fresh catalyst for 60+ days.
• No accelerant in the tape. This is a recovered value name at range highs, not a breakout into blue sky.

Setup & Price Structure

• Spot ~$43.80 (2026-06-04 open); May 22 close $41.35. 52-wk range $22.26–$46.88 — sitting in the top decile of its range, ~7% under the high.
• Stock has roughly DOUBLED off the April-2025 tariff low; the easy mean-reversion leg is done. Above rising MAs but extended within the recovery, not a fresh base-breakout.
• Classic late-stage geometry: buying a maturing recovery AT consensus PT into the top of a multi-quarter range. Beginner-trap read: this is the "was a great idea at $22, is it still at $44?" trap — re-rate vs current price, not cost basis. NOT peak-retail mania (boring footwear, no squeeze dynamics), NOT earnings <3d (Q1 already out), NOT averaging-down (we're flat).
• Risk/reward to consensus PT is roughly 1:1 — fails the >3:1 APPROVE bar.

Catalyst Calendar (next 30 days)

• 2026-06-19 — quarterly dividend pay date ($0.21/share). Cash event, NOT a price catalyst; ex-date already passed.
• Early June 2026 — institutional roadshow (Piper Sandler, Telsey, BTIG, Needham). Can seed reiteration notes (BTIG $50 already out 2026-06-04) but no binary.
• NO earnings in window. Q1 was 2026-05-06; Q2 print is ~early August 2026 (>30 days out) — that is the next real binary, not a near-term one.
• Net: no datable 24h-mover inside 30 days → catalyst_date null.

What Would Change Our Mind

• Bullish re-entry trigger: Q2 (~Aug 2026) shows ORGANIC (ex-Kurt Geiger) revenue re-accelerating AND adjusted EPS inflecting back up YoY — that would convert a played-out recovery into a fresh growth leg worth chasing on a clean breakout above $46.88.
• Theme re-acceleration: a genuine new China-tariff de-escalation or escalation that re-prices the whole reshoring cohort (clustered peer moves), turning consumer-cyclical-rotation back to ACCELERATING.
• Bearish invalidation (if long): weekly close below the 20-EMA (~$40) or loss of the $39 shelf; OR a cut to the $2.00–$2.10 adjusted-EPS guide on the Q2 print; OR organic DTC turning negative (core brand rolling over).

Correlation Notes

• Tariff/China-sourcing basket: moves with footwear/apparel peers re-shoring out of China — DECK, CROX, NKE, SKX, WWW, CRI. SHOO is the high-beta tariff-recovery proxy in this group.
• Consumer-discretionary cyclical: tracks XLY / retail tape and consumer-confidence prints; a discretionary-spend scare hits the whole cohort, not SHOO alone.
• M&A integration idiosyncratic risk: Kurt Geiger execution is a SHOO-specific variable that can decouple it from the footwear basket either direction.
• NO AI/semis correlation — this is pure old-economy consumer; keep it out of any AI-theme cluster-confirmation logic.